HK1159622A1 - 7-piperidinoalkyl-3,4-dihydroquinolone derivative 7--34- - Google Patents
7-piperidinoalkyl-3,4-dihydroquinolone derivative 7--34-Info
- Publication number
- HK1159622A1 HK1159622A1 HK12100046.0A HK12100046A HK1159622A1 HK 1159622 A1 HK1159622 A1 HK 1159622A1 HK 12100046 A HK12100046 A HK 12100046A HK 1159622 A1 HK1159622 A1 HK 1159622A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- piperidinoalkyl
- dihydroquinolone
- derivative
- dihydroquinolone derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008257072 | 2008-10-02 | ||
PCT/JP2009/067441 WO2010038901A1 (fr) | 2008-10-02 | 2009-09-30 | Dérivé de 7-pipéridinoalkyle-3,4-dihydroquinolone |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1159622A1 true HK1159622A1 (en) | 2012-08-03 |
Family
ID=42073652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12100046.0A HK1159622A1 (en) | 2008-10-02 | 2012-01-04 | 7-piperidinoalkyl-3,4-dihydroquinolone derivative 7--34- |
Country Status (29)
Country | Link |
---|---|
US (1) | US8461182B2 (fr) |
EP (1) | EP2344471B1 (fr) |
JP (1) | JP5541279B2 (fr) |
KR (1) | KR20110067026A (fr) |
CN (1) | CN102239159B (fr) |
AR (1) | AR073727A1 (fr) |
AU (1) | AU2009300607C1 (fr) |
BR (1) | BRPI0925343A2 (fr) |
CA (1) | CA2739513A1 (fr) |
CL (1) | CL2011000734A1 (fr) |
CO (1) | CO6321164A2 (fr) |
CY (1) | CY1114165T1 (fr) |
DK (1) | DK2344471T3 (fr) |
ES (1) | ES2424393T3 (fr) |
HK (1) | HK1159622A1 (fr) |
HR (1) | HRP20130728T1 (fr) |
IL (1) | IL212070A (fr) |
MX (1) | MX2011003500A (fr) |
MY (1) | MY154337A (fr) |
NZ (1) | NZ592008A (fr) |
PE (1) | PE20110410A1 (fr) |
PL (1) | PL2344471T3 (fr) |
PT (1) | PT2344471E (fr) |
RS (1) | RS52964B (fr) |
RU (1) | RU2498981C2 (fr) |
SI (1) | SI2344471T1 (fr) |
UA (1) | UA105187C2 (fr) |
WO (1) | WO2010038901A1 (fr) |
ZA (1) | ZA201102315B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011219467A (ja) * | 2010-03-26 | 2011-11-04 | Taisho Pharmaceutical Co Ltd | 7−ピペリジノアルキル−3,4−ジヒドロキノロン誘導体を含有する医薬 |
EP2638014B1 (fr) | 2010-11-08 | 2017-01-04 | Lycera Corporation | Tétrahydroquinolines et composés bicycliques associés n-sulphonylées pour l'inhibition de l'activité rorgamma et le traitement de maladies |
WO2013169864A2 (fr) | 2012-05-08 | 2013-11-14 | Lycera Corporation | Tétrahydro[1,8]naphtyridine-sulfonamide et composés apparentés pour utilisation en tant qu'agonistes de rorγ et dans le traitement d'une maladie |
EP2846804B1 (fr) | 2012-05-08 | 2017-11-29 | Merck Sharp & Dohme Corp. | Tétrahydronaphtyridine et composés bicycliques apparentés pour l'inhibition de l'activité rorgamma et le traitement d'une maladie |
CN109939092B (zh) * | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
WO2015095792A1 (fr) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Acides propioniques de carbamate benzoxazine et dérivés acides pour la modulation de l'activité de rorgamma et le traitement de maladie |
US9809561B2 (en) | 2013-12-20 | 2017-11-07 | Merck Sharp & Dohme Corp. | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
US9663502B2 (en) | 2013-12-20 | 2017-05-30 | Lycera Corporation | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease |
US10532088B2 (en) | 2014-02-27 | 2020-01-14 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods |
JP6728061B2 (ja) | 2014-05-05 | 2020-07-22 | リセラ・コーポレイションLycera Corporation | RORγアゴニストとして用いるテトラヒドロキノリンスルホンアミド及び関連化合物ならびに疾患の治療 |
JP6523337B2 (ja) | 2014-05-05 | 2019-05-29 | リセラ・コーポレイションLycera Corporation | RORγのアゴニストとしての使用及び疾患治療のためのベンゼンスルホンアミド及び関連化合物 |
WO2016130818A1 (fr) | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Composés pyrazole substitués utilisés en tant qu'inhibiteurs de rorgammat et utilisations desdits composés |
CA2982847A1 (fr) | 2015-05-05 | 2016-11-10 | Lycera Corporation | Sulfonamides de dihydro-2h-benzo[b][1,4]oxazine et composes apparentes destines a etre utilises comme agonistes de ror.gamma. et pour le traitement de maladies |
MX2017016134A (es) | 2015-06-11 | 2018-08-15 | Lycera Corp | Aril dihidro-2h-benzo[b][1,4]oxazina sulfonamida y compuestos relacionados para uso como agonistas de rory y el tratamiento de enfermedad. |
WO2017075185A1 (fr) | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | Acides benzoïques à substitution hétéroaryle en tant qu'inhibiteurs de rorgammat et leurs utilisations |
CA3002846A1 (fr) | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | Composes pyrazoles bicycliques substitues en tant qu'inhibiteurs de rorgammat et leurs utilisations |
EP3368539B1 (fr) | 2015-10-27 | 2020-12-02 | Merck Sharp & Dohme Corp. | Composés indazole substitués utilisés en tant qu'inhibiteurs de ror gamma t et utilisations associées |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE187172T1 (de) * | 1995-09-15 | 1999-12-15 | Sanofi Synthelabo | Chinolin-2-on derivate als serotonin antagonisten |
JP2005523237A (ja) * | 2001-10-01 | 2005-08-04 | 大正製薬株式会社 | Mch受容体アンタゴニスト |
WO2003035624A1 (fr) * | 2001-10-25 | 2003-05-01 | Takeda Chemical Industries, Ltd. | Compose quinoline |
WO2004087680A1 (fr) * | 2003-03-31 | 2004-10-14 | Taisho Pharmaceutical Co., Ltd. | Nouveaux derives de quinazoline et leur utilisation therapeutique |
US20050197350A1 (en) * | 2003-03-31 | 2005-09-08 | Taisho Pharmaceutical Co., Ltd. | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
US20050209274A1 (en) | 2004-02-26 | 2005-09-22 | Lynch John K | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
CN1976905A (zh) * | 2004-03-30 | 2007-06-06 | 大正制药株式会社 | 嘧啶衍生物以及与其应用有关的治疗方法 |
JP2008514546A (ja) * | 2004-09-30 | 2008-05-08 | 大正製薬株式会社 | ピリジン誘導体及びその使用に関連する治療法 |
JPWO2008044632A1 (ja) | 2006-10-06 | 2010-02-12 | 大正製薬株式会社 | 1−ナフチルアルキルピペリジン誘導体 |
-
2009
- 2009-09-30 MX MX2011003500A patent/MX2011003500A/es active IP Right Grant
- 2009-09-30 AU AU2009300607A patent/AU2009300607C1/en not_active Ceased
- 2009-09-30 DK DK09817928.6T patent/DK2344471T3/da active
- 2009-09-30 RU RU2011117161/04A patent/RU2498981C2/ru not_active IP Right Cessation
- 2009-09-30 ES ES09817928T patent/ES2424393T3/es active Active
- 2009-09-30 PE PE2011000810A patent/PE20110410A1/es not_active Application Discontinuation
- 2009-09-30 SI SI200930738T patent/SI2344471T1/sl unknown
- 2009-09-30 RS RS20130370A patent/RS52964B/en unknown
- 2009-09-30 US US13/122,281 patent/US8461182B2/en not_active Expired - Fee Related
- 2009-09-30 KR KR1020117007343A patent/KR20110067026A/ko not_active Application Discontinuation
- 2009-09-30 CN CN200980149091.2A patent/CN102239159B/zh not_active Expired - Fee Related
- 2009-09-30 EP EP09817928.6A patent/EP2344471B1/fr active Active
- 2009-09-30 MY MYPI2011001430A patent/MY154337A/en unknown
- 2009-09-30 NZ NZ592008A patent/NZ592008A/en not_active IP Right Cessation
- 2009-09-30 UA UAA201105428A patent/UA105187C2/uk unknown
- 2009-09-30 WO PCT/JP2009/067441 patent/WO2010038901A1/fr active Application Filing
- 2009-09-30 CA CA2739513A patent/CA2739513A1/fr not_active Abandoned
- 2009-09-30 BR BRPI0925343-2A patent/BRPI0925343A2/pt not_active IP Right Cessation
- 2009-09-30 JP JP2011513768A patent/JP5541279B2/ja not_active Expired - Fee Related
- 2009-09-30 PT PT98179286T patent/PT2344471E/pt unknown
- 2009-09-30 PL PL09817928T patent/PL2344471T3/pl unknown
- 2009-10-01 AR ARP090103798A patent/AR073727A1/es unknown
-
2011
- 2011-03-29 ZA ZA2011/02315A patent/ZA201102315B/en unknown
- 2011-03-30 CO CO11038711A patent/CO6321164A2/es active IP Right Grant
- 2011-03-31 IL IL212070A patent/IL212070A/en not_active IP Right Cessation
- 2011-04-01 CL CL2011000734A patent/CL2011000734A1/es unknown
-
2012
- 2012-01-04 HK HK12100046.0A patent/HK1159622A1/xx not_active IP Right Cessation
-
2013
- 2013-07-25 CY CY20131100633T patent/CY1114165T1/el unknown
- 2013-08-01 HR HRP20130728AT patent/HRP20130728T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256310A1 (zh) | N-磺酰基吡咯衍生物 | |
HRP20130728T1 (en) | 7-piperidinoalkyl-3,4-dihydroquinolone derivative | |
SI2384326T1 (sl) | Pirolo(2,3-d)pirimidinske spojine | |
EP2376493A4 (fr) | Dérivé de dihydropyrimidopyrimidine | |
EP2380877A4 (fr) | Dérivé de pyridine-3-carboxyamide | |
IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
EP2376494A4 (fr) | Dérivés de dihydropyrimidopirymidine | |
HK1158189A1 (en) | Morpholinopurine derivative | |
EP2331543A4 (fr) | Dérivés 3-désazanéplanocine | |
EP2291078A4 (fr) | Dérivés d'oxazolobenzimidazole | |
EP2269993A4 (fr) | Dérivé de 2-aminoquinazoline | |
ZA201005769B (en) | Bicycloamine derivative | |
IL208623A0 (en) | Cyclopentylacrylamide derivative | |
ZA201006992B (en) | Hydroxyquinoxalinecarboxamide derivative | |
SI2266990T1 (sl) | Spojina 3-fenilpirazolo(5,1-b)tiazola | |
EP2292613A4 (fr) | Dérivés de dihydroindolinone | |
EP2248811A4 (fr) | Dérivé de 2-oxochromène | |
IL212683A0 (en) | Biphenylacetamide derivative | |
ZA201005346B (en) | 3,8-diaminotetrahydroquinoline derivative | |
EP2332925A4 (fr) | Nouveau dérivé de dihydrotriazine | |
EP2328892A4 (fr) | Dérivé d'oxotétrahydrofurann-2-yl-benzimidazole | |
HK1206742A1 (en) | Aminopropylidene derivative | |
GB0810164D0 (en) | Wedge-dek, shower-floor gradient-former | |
GB0808831D0 (en) | . | |
GB0811138D0 (en) | . |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181001 Effective date: 20181002 |